Phenotypic patient profiling for improved implementation of guideline-directed medical therapy: An exploratory

Sumant P Radhoe1, Pascal R D Clephas1, Gerard C M Linssen2

  • 1Department of Cardiology, Thorax Center, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.

Insights

Implementing guideline-recommended heart failure (HF) treatments is difficult. A new study found that nearly 40% of chronic HF patients fit into European Heart Failure Association (HFA) defined profiles, suggesting phenotype-specific care can improve treatment adherence.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Guideline-recommended pharmacological treatment for heart failure (HF) presents implementation challenges.
  • The European Heart Failure Association (HFA) developed patient profiles based on clinical characteristics to guide individualized HF treatment.
  • Optimizing treatment based on patient profiles may enhance guideline adherence and patient outcomes.

Purpose of the Study:

  • To determine the distribution of HFA-defined patient profiles within a large, real-world cohort of chronic heart failure patients.
  • To assess the current treatment patterns associated with these identified patient profiles.

Main Methods:

  • Utilized data from 4,455 chronic HF patients with left ventricular ejection fraction ≤40%.
  • Classified patients into eleven phenotypic profiles based on heart rate, blood pressure, atrial fibrillation, chronic kidney disease, and hyperkalemia.
  • Analyzed the proportion of patients fitting into the HFA profiles and their treatment characteristics.

Main Results:

  • 1,640 patients (36.8%) were successfully classified into one of the eleven HFA patient profiles.
  • Three specific profiles, characterized by heart rate >60 bpm, normal blood pressure, and absence of hyperkalemia, each represented over 5% of the classified population.
  • Identified specific patient phenotypes that are prevalent in real-world chronic HF populations.

Conclusions:

  • A significant proportion (nearly 40%) of the real-world chronic HF population can be categorized using the HFA's eleven phenotypic profiles.
  • These phenotype-specific classifications are clinically relevant for improving guideline implementation in heart failure management.
  • Tailoring treatment to patient profiles holds promise for enhancing individualized care and adherence to best practices in HF.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
20
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
129
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K